Mirati Theraps Drug Patent Portfolio

Mirati Theraps owns 1 orange book drug protected by 1 US patent Given below is the list of Mirati Theraps's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10689377 KRas G12C inhibitors 17 May, 2037
Active


Given below is the list of recent legal activities going on the following drug patents of Mirati Theraps.

Activity Date Patent Number
Patent litigations
Mail O.P. Petition Decision 21 Mar, 2024 US10689377
Email Notification 21 Mar, 2024 US10689377
Mail-Record Petition Decision of Granted to Make Entity Status large 19 Mar, 2024 US10689377
Record Petition Decision of Granted to Make Entity Status large 18 Mar, 2024 US10689377
O.P. Petition Decision 16 Mar, 2024 US10689377
Petition Entered 09 Jan, 2024 US10689377
Entity Status Set To Undiscounted (Initial Default Setting or Status Change) 09 Jan, 2024 US10689377
Payment of Maintenance Fee under 1.28(c) 09 Jan, 2024 US10689377
Payment of Maintenance Fee, 4th Yr, Small Entity 26 Dec, 2023 US10689377
Change in Power of Attorney (May Include Associate POA) 24 Jul, 2023 US10689377
Email Notification 24 Jul, 2023 US10689377
Electronic Review 24 Jul, 2023 US10689377
Change in Power of Attorney (May Include Associate POA) 21 Jan, 2022 US10689377
Email Notification 21 Jan, 2022 US10689377
Correspondence Address Change 19 Jan, 2022 US10689377


Mirati Theraps's Family Patents

Mirati Theraps drugs have patent protection in a total of 22 countries. It's US patent count contributes only to 23.3% of its total global patent coverage. Click below to unlock the full patent family tree.

Family Patents



Mirati Theraps Drug List

Given below is the complete list of Mirati Theraps's drugs and the patents protecting them.


1. Krazati

Krazati is protected by 1 patent, which is still active. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10689377 KRas G12C inhibitors 17 May, 2037
(12 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Krazati's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List